about
Acute ischemic stroke in pediatric patientsWorkflow for automated quantification of cerebromicrovascular gelatinase activity.Evolution of intracerebral hemorrhage after intravenous tPA: reversal of harmful effects with mast cell stabilizationHigher neutrophil counts before thrombolysis for cerebral ischemia predict worse outcomes.Extent of secondary intraventricular hemorrhage is an independent predictor of outcomes in intracerebral hemorrhage: data from the Helsinki ICH Study.Rodent models of hemorrhagic stroke.SMASH-U: a proposal for etiologic classification of intracerebral hemorrhage.Post-ischemic leakiness of the blood-brain barrier: a quantitative and systematic assessment by Patlak plots.An optimized mouse model for transient ischemic attack.Ultraearly thrombolysis in acute ischemic stroke is associated with better outcome and lower mortality.Patient outcomes from symptomatic intracerebral hemorrhage after stroke thrombolysis.Stroke mimics and intravenous thrombolysis.Intravenous thrombolysis in ischemic stroke patients with isolated homonymous hemianopia.Predicting outcome of IV thrombolysis-treated ischemic stroke patients: the DRAGON score.Long-term evolution of diffusion tensor indices after temporary experimental ischemic stroke in rats.Symptomatic intracranial hemorrhage after stroke thrombolysis: the SEDAN score.Intravenous thrombolysis for acute ischemic stroke patients presenting with mild symptoms.Outcome of ischemic stroke patients with serious post-thrombolysis neurological deficits.Intravenous thrombolysis in ischemic stroke patients with isolated homonymous hemianopia: analysis of Safe Implementation of Thrombolysis in Stroke-International Stroke Thrombolysis Register (SITS-ISTR).Thrombolysis of basilar artery occlusion: impact of baseline ischemia and time.Intravenous thrombolysis of basilar artery occlusion: thrombus length versus recanalization success.Predicting functional outcome and symptomatic intracranial hemorrhage in patients with acute ischemic stroke: a glimpse into the crystal ball?Trends in Door-to-Thrombolysis Time in the Safe Implementation of Stroke Thrombolysis Registry: Effect of Center Volume and Duration of Registry Membership.Review of the ENCHANTED Trial (Enhanced Control of Hypertension and Thrombolysis Stroke Study): How Low Can We Go With Intravenous Tissue-Type Plasminogen Activator Dose and Blood Pressure Level?Prehospital Phase of the Stroke Chain of Survival: A Prospective Observational Study.Current treatment of basilar artery occlusion.In-hospital cardiac complications after intracerebral hemorrhage.Lost potential of kidney and liver donors amongst deceased intracerebral hemorrhage patients.Higher baseline international normalized ratio value correlates with higher mortality in intracerebral hemorrhage during warfarin use.Sickle cell disease and stroke.Time window for recanalization in basilar artery occlusion: Speculative synthesis.Comparison of all 19 published prognostic scores for intracerebral hemorrhage.Reliability of intracerebral hemorrhage classification systems: A systematic review.A novel combined model of intracerebral and intraventricular hemorrhage using autologous blood-injection in rats.Symptomatic post-thrombolytic intracerebral hemorrhage is not related to the cause of stroke.Gender differences in the clinical course of Finnish gelsolin amyloidosis.Emergency computed tomography in patients with first seizure.Natural History of Perihematomal Edema and Impact on Outcome After Intracerebral Hemorrhage.Simultaneous Multiple Intracerebral Hemorrhages (SMICH).Natural course of Finnish gelsolin amyloidosis.
P50
Q26991876-054D9633-5D31-467B-81EF-EB6048539453Q30487313-428E332D-FFAE-442E-B028-FBDC9ECE1152Q30563965-F6E84D19-761B-4EBF-9813-C2364E7187D1Q30671155-D1DDE3A5-0D5F-4BA7-A169-DABB3BD6C4ABQ30884131-7F131124-0F97-4229-8BE7-0F6FE847F0A1Q33320691-CC215509-944E-4E29-A21C-162467C87246Q33402651-1327BD24-BAE5-4B44-9B9C-DA0087459CDCQ33466585-B12D6E53-E023-45F9-9ECD-3831EF0ADA69Q33524999-382282EE-FCEF-4836-B3BD-89A941230358Q33532357-9372A641-4A86-4C14-8BBA-DC8326278033Q33946251-D32782A3-EB9D-4EA9-BFB3-18BC4103300FQ34048453-1E2A5DB1-AC1E-4B4C-88F6-E434C402708DQ34148887-5187E2F3-8D80-4E2B-A04E-A5819A8633A6Q34152485-DC9EAE0F-8AE9-45CA-AA7C-9B91ED63173CQ34156508-81DD6DA6-41CA-44DD-9E9C-5657B0073321Q34241228-0DB2F50D-0A43-4B83-AD5B-80EEDDB43306Q34262372-B0D4ECF6-ACE8-4434-9D86-81618615A9F6Q34326883-C6796D9E-1B02-4890-AF2C-2689E7135B27Q34343420-576FFB74-EFE8-40B9-A66D-EEFE95C7A019Q34638795-D48A8081-30A4-444A-A2D8-8E8C7E2A31F1Q35159644-DD02B34D-D1F0-461A-B5F6-07883EE5761CQ35556328-F33AF3FA-AD6F-4880-BAD2-12271F3EAA90Q35591355-A7FE4608-3EE6-4E4A-A227-D21FDFDE7E85Q36176697-76964969-A4A3-4147-8192-A479B3DC6853Q36956672-03B1056B-FA61-496A-B90D-97040E75E8F7Q38044933-F6DB6FED-6BF5-4D8B-AEAE-6451FACC32DEQ38136353-45D460EF-6B25-4E6F-991F-CBCB7677EDF8Q38160576-2FA5CC6F-B3AA-476C-B608-32AA01716269Q38180538-F26218DB-2357-4BB2-9D05-5FC39BE7AFFAQ38208733-7A1154F6-8D6C-4DE4-B111-DEE67ACA6928Q38635047-C03667B2-C24D-4AF0-9683-4141E5DE62DDQ38675212-75ED7F0C-746E-4B45-9BE3-94876E287769Q38811367-C2499DD5-C127-4288-A597-8320F7F10563Q39195414-B1408921-26F6-4899-B0EA-E174EB27F684Q39425519-2CC81034-A975-4CDD-9D66-66B3F62B1DD6Q40067141-FE0C7B88-ACC9-49FB-8559-26A0A708B07EQ40238411-23A58FD4-85BD-4CFA-81F1-1ABC656E66B2Q40301146-5805F099-AAD9-4D06-B135-CFF781BC59AFQ40321125-07A72447-AE6B-478F-9B13-92235F83E084Q41413049-51A072C4-3BD6-462F-B445-7F74944C546A
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0001-9095-2344
@en
name
D Strbian
@ast
D Strbian
@en
D Strbian
@nl
type
label
D Strbian
@ast
D Strbian
@en
D Strbian
@nl
altLabel
Daniel Strbian
@en
prefLabel
D Strbian
@ast
D Strbian
@en
D Strbian
@nl
P106
P31
P496
0000-0001-9095-2344